We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Urology

Journal Scan / Research · July 01, 2022

Rare Germline Variants Are Associated With Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment

European Urology


Additional Info

Disclosure statements are available on the authors' profiles:

European Urology
Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study
Eur Urol 2022 May 31;[EPub Ahead of Print], D Burns, E Anokian, EJ Saunders, RG Bristow, M Fraser, J Reimand, T Schlomm, G Sauter, B Brors, J Korbel, J Weischenfeldt, SM Waszak, NM Corcoran, CH Jung, BJ Pope, CM Hovens, G Cancel-Tassin, O Cussenot, M Loda, C Sander, VM Hayes, K Dalsgaard Sorensen, YJ Lu, FC Hamdy, CS Foster, V Gnanapragasam, A Butler, AG Lynch, CE Massie, , DJ Woodcock, CS Cooper, DC Wedge, DS Brewer, Z Kote-Jarai, RA Eeles

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading